HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enis Ozyar Selected Research

Carcinoma (Carcinomatosis)

1/2023Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study.
7/2012High daily fraction dose external radiotherapy for T1 glottic carcinoma: treatment results and prognostic factors.
9/2006Evaluation of radiotherapy response of cervical carcinoma with gray scale and color Doppler ultrasonography: resistive index correlation with magnetic resonance findings.
1/2005Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enis Ozyar Research Topics

Disease

17Neoplasms (Cancer)
11/2023 - 01/2005
12Nasopharyngeal Carcinoma
01/2021 - 01/2002
5Neoplasm Metastasis (Metastasis)
02/2023 - 10/2005
4Carcinoma (Carcinomatosis)
01/2023 - 01/2005
3Lymphoma (Lymphomas)
09/2022 - 10/2003
2Laryngeal Neoplasms (Laryngeal Cancer)
01/2022 - 10/2005
2Lung Neoplasms (Lung Cancer)
11/2020 - 02/2012
2Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2020 - 02/2008
2Disease Progression
09/2020 - 03/2009
2Melanoma (Melanoma, Malignant)
12/2019 - 07/2006
2Paraganglioma (Paragangliomas)
01/2019 - 01/2019
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
03/2010 - 01/2002
2Hodgkin Disease (Hodgkin's Disease)
01/2009 - 11/2004
2Hypothyroidism
01/2007 - 04/2006
2Squamous Cell Carcinoma of Head and Neck
07/2006 - 10/2005
2Trismus (Lockjaw)
04/2006 - 10/2005
1Radiodermatitis
11/2023
1Breast Neoplasms (Breast Cancer)
02/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2023
1Pelvic Neoplasms
01/2023
1Thrombosis (Thrombus)
04/2022
1Hepatocellular Carcinoma (Hepatoma)
04/2022
1Cholangiocarcinoma
12/2021
1Rhabdoid Tumor (Rhabdoid Tumors)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Adenocarcinoma
01/2020
1Rectal Neoplasms (Rectal Cancer)
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
12/2019
1Brain Neoplasms (Brain Tumor)
12/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2017
1Chondrosarcoma
01/2013
1Chordoma
01/2013
1AIDS-Related Complex (ARC)
05/2012
1Residual Neoplasm
04/2011
1Retinoblastoma (Glioblastoma, Retinal)
09/2010
1Rheumatoid Arthritis
05/2010
1Anemia
01/2009
1Leukocytosis (Pleocytosis)
01/2009
1Kaposi Sarcoma (Kaposi's Sarcoma)
07/2006
1Melanosis (Freckles)
07/2006
1Dental Caries (Decay, Dental)
04/2006
1Hypersensitivity (Allergy)
08/2004
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
08/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2003
1Endometrial Neoplasms (Endometrial Cancer)
09/2002

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
03/2009 - 01/2004
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2012 - 08/2007
1histaminol (IMET)IBA
02/2023
1Prostate-Specific Antigen (Semenogelase)IBA
01/2021
1Trinitrotoluene (TNT)IBA
01/2020
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2017
1Rituximab (Mabthera)FDA Link
05/2010
1Docetaxel (Taxotere)FDA Link
03/2009
1Thyroid HormonesIBA
01/2007
14-nitrophenyl beta-cellobiosideIBA
10/2006
1Indicators and Reagents (Reagents)IBA
10/2005
1Fluorouracil (Carac)FDA LinkGeneric
01/2005
1Interleukin-10 (Interleukin 10)IBA
01/2004
1PlatinumIBA
01/2004
1IfosfamideFDA LinkGeneric
01/2004
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2004

Therapy/Procedure

40Radiotherapy
11/2023 - 01/2002
9Therapeutics
09/2020 - 10/2003
6Drug Therapy (Chemotherapy)
01/2020 - 03/2002
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2022 - 09/2010
3Chemoradiotherapy
01/2023 - 01/2005
3Brachytherapy
09/2020 - 01/2002
3Aftercare (After-Treatment)
01/2020 - 04/2011
3Neoadjuvant Therapy
01/2020 - 08/2007
2Adjuvant Radiotherapy
07/2006 - 09/2002
1Re-Irradiation
01/2021
1TNT protocol
01/2020
1Particle Accelerators
01/2013
1Cryotherapy (Therapy, Cold)
09/2010
1Induced Hyperthermia (Thermotherapy)
09/2010
1Premedication
03/2009
1ABVD protocol
01/2009
1Lasers (Laser)
07/2006
1Induction Chemotherapy
01/2005